Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

[Hypertensive leg ulcers: epidemiological characteristics and prognostic factors for healing in a prospective cohort].

Senet P, Beneton N, Debure C, Modiano P, Lok C, Bedane C, Truchetet F, Fays-Bouchon S, Vicaut E, Chosidow O; Angio-dermatologie de la SFD.

Ann Dermatol Venereol. 2012 May;139(5):346-9. doi: 10.1016/j.annder.2011.09.191. Epub 2012 Feb 1. French.

PMID:
22578337
2.

Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial.

Senet P, Vicaut E, Beneton N, Debure C, Lok C, Chosidow O.

Arch Dermatol. 2011 Aug;147(8):926-30. doi: 10.1001/archdermatol.2011.84. Epub 2011 Apr 11.

PMID:
21482863
3.

Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.

Rees RS, Robson MC, Smiell JM, Perry BH.

Wound Repair Regen. 1999 May-Jun;7(3):141-7.

5.
6.
7.

Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.

Steed DL.

Plast Reconstr Surg. 2006 Jun;117(7 Suppl):143S-149S; discussion 150S-151S. Review.

PMID:
16799381
8.

The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration.

Tautenhahn J, Lobmann R, Koenig B, Halloul Z, Lippert H, Buerger T.

Vasc Health Risk Manag. 2008;4(3):683-9.

10.

The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.

Lantis JC 2nd, Marston WA, Farber A, Kirsner RS, Zhang Y, Lee TD, Cargill DI, Slade HB.

J Vasc Surg. 2013 Aug;58(2):433-9. doi: 10.1016/j.jvs.2012.12.055. Epub 2013 Apr 12.

11.

Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers.

Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP.

Adv Skin Wound Care. 2005 Jun;18(5 Pt 1):258-66.

PMID:
15942317
12.

Impact of protein deficiency on venous ulcer healing.

Legendre C, Debure C, Meaume S, Lok C, Golmard JL, Senet P.

J Vasc Surg. 2008 Sep;48(3):688-93. doi: 10.1016/j.jvs.2008.04.012. Epub 2008 Jun 25.

13.

Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial.

Abbruzzese L, Rizzo L, Fanelli G, Tedeschi A, Scatena A, Goretti C, Macchiarini S, Piaggesi A.

Int J Low Extrem Wounds. 2009 Sep;8(3):134-40. doi: 10.1177/1534734609344140.

PMID:
19703948
14.

Management of chronic pressure ulcers: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(3):1-203. Epub 2009 Jul 1.

15.

Diabetic foot ulcers treated with becaplermin and TheraGauze, a moisture-controlling smart dressing: a randomized, multicenter, prospective analysis.

Landsman A, Agnew P, Parish L, Joseph R, Galiano RD.

J Am Podiatr Med Assoc. 2010 May-Jun;100(3):155-60.

PMID:
20479444
16.

Risk factors related to the failure of venous leg ulcers to heal with compression treatment.

Milic DJ, Zivic SS, Bogdanovic DC, Karanovic ND, Golubovic ZV.

J Vasc Surg. 2009 May;49(5):1242-7. doi: 10.1016/j.jvs.2008.11.069. Epub 2009 Feb 23.

17.

Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo-controlled, double-blind pilot clinical trial.

Whitmont K, McKelvey KJ, Fulcher G, Reid I, March L, Xue M, Cooper A, Jackson CJ.

Int Wound J. 2015 Aug;12(4):422-7. doi: 10.1111/iwj.12125. Epub 2013 Jul 15.

PMID:
23848141
18.

A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report.

Krupski WC, Reilly LM, Perez S, Moss KM, Crombleholme PA, Rapp JH.

J Vasc Surg. 1991 Oct;14(4):526-32; discussion 532-6.

PMID:
1920650
19.

Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers.

Meaume S, Ourabah Z, Cartier H, Granel-Brocard F, Combemale P, Bressieux JM, Bohbot S.

J Wound Care. 2005 Jul;14(7):329-34.

PMID:
16048220
20.

Long-term successful healing of ulcerated necrobiosis lipoidica after topical therapy with becaplermin.

Tauveron V, Rosen A, Khashoggi M, Abdallah-Lotf M, Machet L.

Clin Exp Dermatol. 2013 Oct;38(7):745-7. doi: 10.1111/ced.12123. Epub 2013 Aug 21.

PMID:
23962308

Supplemental Content

Support Center